Trials / Completed
CompletedNCT01485692
Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation
Safety and Efficacy of Four Intramuscular Interventions for the Management of Acute Psychomotor Agitation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the efficacy and safety of four options of medications in the management of acute psychomotor agitation,or violence and aggression situations in health services. All of the treatment options are already approved and currently used for this purpose. The options are: haloperidol plus midazolam, haloperidol plus promethazine, olanzapine and ziprasidone. The investigators hypothesized that all treatment options are effective in the treatment of acute agitation, but the combination haloperidol plus promethazine could elicit more adverse affects than the others.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | haloperidol+promethazine | haloperidol, 2,5mg plus promethazine,25mg, intramuscular injection after baseline measures of agitation, could be repeated twice, if necessary, in the 90 minutes period of observation |
| DRUG | haloperidol + midazolam | haloperidol, 2,5mg plus midazolam, 7,5 mg, intramuscular injection after baseline measures of agitation, could be repeated twice, if necessary, between the 90 minutes period of observation |
| DRUG | olanzapine | olanzapine, 10mg, intramuscular injection, after baseline measures of agitation, could be repeated twice, if necessary, between the 90 minutes of observation |
| DRUG | Ziprasidone | ziprasidone, 10 mg, intramuscular injection after baseline measures of agitation, could be repeated twice, if necessary, between the 90 minutes period of observation |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2011-12-05
- Last updated
- 2011-12-05
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT01485692. Inclusion in this directory is not an endorsement.